ACRS Initiated Coverage by Canaccord Genuity -- Rating Set to Bu
· gurufocus.com
Aclaris Therapeutics (ACRS) Receives Buy Rating from Canaccord Genuity On October 03, 2023, Aclaris Therapeutics (ACRS) received a new analyst rating as Cana
Aclaris Therapeutics ACRS Receives Buy Rating from Canaccord Genuity
On October 03, 2023, Aclaris Therapeutics (ACRS) received a new analyst rating as Canaccor...